DENTSPLY SIRONA (NASDAQ:XRAY) Stock Rating Reaffirmed by Barclays

Barclays reaffirmed their hold rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a research report sent to investors on Sunday morning, AnalystRatings.com reports. They currently have a $64.00 target price on the medical instruments supplier’s stock.

XRAY has been the topic of a number of other reports. JPMorgan Chase & Co. lowered shares of DENTSPLY SIRONA from an overweight rating to a neutral rating and set a $65.00 target price on the stock. in a report on Wednesday, December 11th. They noted that the move was a valuation call. ValuEngine lowered shares of DENTSPLY SIRONA from a hold rating to a sell rating in a report on Wednesday, October 2nd. HC Wainwright reissued a hold rating and set a $60.00 target price on shares of DENTSPLY SIRONA in a report on Friday, November 15th. BidaskClub lowered shares of DENTSPLY SIRONA from a buy rating to a hold rating in a report on Friday, December 13th. Finally, Zacks Investment Research raised shares of DENTSPLY SIRONA from a hold rating to a buy rating and set a $60.00 target price on the stock in a report on Tuesday, December 10th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and four have assigned a buy rating to the stock. DENTSPLY SIRONA has a consensus rating of Hold and a consensus target price of $58.27.

XRAY opened at $60.71 on Friday. DENTSPLY SIRONA has a fifty-two week low of $40.26 and a fifty-two week high of $60.87. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.08 and a quick ratio of 1.39. The firm has a market capitalization of $13.34 billion, a price-to-earnings ratio of 84.32, a PEG ratio of 1.87 and a beta of 0.94. The company’s 50 day moving average price is $57.62 and its two-hundred day moving average price is $55.08.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.57 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.07. DENTSPLY SIRONA had a net margin of 4.08% and a return on equity of 10.08%. The firm had revenue of $962.10 million for the quarter, compared to analyst estimates of $940.38 million. During the same period in the previous year, the firm posted $0.38 EPS. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. As a group, equities research analysts predict that DENTSPLY SIRONA will post 2.46 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Stockholders of record on Friday, December 27th were paid a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date was Thursday, December 26th. DENTSPLY SIRONA’s dividend payout ratio is currently 19.90%.

In other news, Director Michael C. Alfano sold 10,665 shares of the company’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $56.27, for a total value of $600,119.55. Following the sale, the director now directly owns 15,153 shares of the company’s stock, valued at approximately $852,659.31. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 0.62% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in the stock. Nisa Investment Advisors LLC lifted its position in shares of DENTSPLY SIRONA by 0.5% during the 4th quarter. Nisa Investment Advisors LLC now owns 60,811 shares of the medical instruments supplier’s stock valued at $3,441,000 after acquiring an additional 304 shares during the period. Rational Advisors LLC lifted its position in shares of DENTSPLY SIRONA by 102.7% during the 3rd quarter. Rational Advisors LLC now owns 675 shares of the medical instruments supplier’s stock valued at $36,000 after acquiring an additional 342 shares during the period. Alpha Windward LLC lifted its position in shares of DENTSPLY SIRONA by 5.1% during the 4th quarter. Alpha Windward LLC now owns 8,942 shares of the medical instruments supplier’s stock valued at $506,000 after acquiring an additional 430 shares during the period. Diversified Trust Co lifted its position in shares of DENTSPLY SIRONA by 6.4% during the 3rd quarter. Diversified Trust Co now owns 7,529 shares of the medical instruments supplier’s stock valued at $401,000 after acquiring an additional 452 shares during the period. Finally, Huntington National Bank lifted its position in shares of DENTSPLY SIRONA by 66.0% during the 4th quarter. Huntington National Bank now owns 1,260 shares of the medical instruments supplier’s stock valued at $71,000 after acquiring an additional 501 shares during the period. Institutional investors own 94.38% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Further Reading: How prevalent are 12b-1 fees?

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.